Farnesylated prelamin A induces fibroblast polarity defects in premature aging disorders by inhibiting nesprin-2–SUN2 LINC complex function
Journal of Cell Science · 2026
DOI: 10.1242/jcs.264488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2026. Verfasst von Chonkit Lio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Science, University of Macau, Taipa, Macau, China. Hauptthemen laut MEDLINE: Nuclear Proteins, Fibroblasts, Aging, Premature, Cell Polarity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundo para o Desenvolvimento das Ciências e da Tecnologia, Columbia University, NIH-GMS.
Abstract (Originalsprache)
Disrupted processing of prelamin A (encoded by LMNA) causes Hutchinson–Gilford progeria syndrome (HGPS) and related premature aging disorders. The farnesylated prelamin A variant produced in HGPS, termed progerin, alters actin–nuclear interactions mediated by nesprin-2 and SUN2 linker of nucleoskeleton and cytoskeleton (LINC) complexes, resulting in defective cell polarization. To explore further how prelamin A causes these cellular defects, we examined other disease-causing variants that prevent cleavage of lamin A or reduce the activity of the processing enzyme ZMPSTE24. Accumulation of prelamin A or an uncleaved variant in cells reduced diffusional mobilities of nesprin-2 and SUN2 and inhibited their function in cell polarization in a farnesylation-dependent manner. Expression of short carboxyl-terminal tail fragments of prelamin A variants disrupted cell polarity in a farnesylation-dependent fashion. These results show that retention of the farnesyl moiety in the tails of prelamin A or its variants is the common element responsible for disrupting actin force transmission to the nucleus in premature aging syndromes and support the idea that altered function of actin-dependent LINC complexes is a critical component of premature aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Science, University of Macau, Taipa, Macau, China.
- MOE Frontier Science Centre for Precision Oncology, University of Macau, Taipa, Macau, China.
- Department of Medicine, Columbia University, New York, NY 10032, USA.
- Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
ORCID-Profile: Yuexia Wang, Paige C Wilson, Susumu Antoku, Cecilia Östlund, Howard J Worman, Wakam Chang, Gregg G Gundersen
Förderung
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- Columbia University
- NIH-GMS
- NIH-NIA
- NIGMS NIH HHS
- NIH HHS
- NIA NIH HHS
- Science and Technology Development Fund, Macau SAR
Zitieren
APA
Lio, C., Wang, Y., Wilson, P. C., Li, Y., Antoku, S., Östlund, C., Shin, J. Y., Worman, H. J., Chang, W., & Gundersen, G. G. (2026). Farnesylated prelamin A induces fibroblast polarity defects in premature aging disorders by inhibiting nesprin-2–SUN2 LINC complex function. Journal of Cell Science. https://doi.org/10.1242/jcs.264488
Vancouver
Lio C, Wang Y, Wilson PC, Li Y, Antoku S, Östlund C, et al. Farnesylated prelamin A induces fibroblast polarity defects in premature aging disorders by inhibiting nesprin-2–SUN2 LINC complex function. Journal of Cell Science. 2026. doi:10.1242/jcs.264488
BibTeX
@article{Lio2026,
author = {Lio, Chonkit and Wang, Yuexia and Wilson, Paige C and Li, Yutao and Antoku, Susumu and Östlund, Cecilia and Shin, Ji-Yeon and Worman, Howard J and Chang, Wakam and Gundersen, Gregg G},
title = {Farnesylated prelamin A induces fibroblast polarity defects in premature aging disorders by inhibiting nesprin-2–SUN2 LINC complex function},
journal = {Journal of Cell Science},
year = {2026},
doi = {10.1242/jcs.264488}
}
EUVIMED